Connection

Stephen Kent to HIV Integrase Inhibitors

Back to Details
This is a "connection" page, showing publications Stephen Kent has written about HIV Integrase Inhibitors.
Stephen Kent
Connection Strength
0.157
HIV Integrase Inhibitors
  1. The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. Lancet HIV. 2018 05; 5(5):e221-e230.
    View in: PubMed
    Score: 0.157
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.